Product Information

LANSOPRAZOLE DR 15 MG ODT is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.8751 per EA under NDC 68382077177. Its NADAC has been published 331 times since Apr 22, 2020.

FDA first approved this application on Nov 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the LANSOPRAZOLE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LANSOPRAZOLE DR 15 MG ODT

LANSOPRAZOLE
$1.8751per EA
High Outlier

Strength

15 mg/1

NDC

68382077177

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA200816

FDA Approved

11/27/2018

TE Code

AB

On Market Since

11/30/2018

Pharmacological Classes

Inhibition Gastric Acid Secretion
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for LANSOPRAZOLE DR 15 MG ODT has been published 331 times since Apr 22, 2020, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8751 per EA
All-time high$9.1795 (Jul 15, 2020)
All-time low$1.5080 (Apr 22, 2026)
52-week high$1.8751
52-week low$1.5080
Median price$3.6404
Average price$4.2162
Largest weekly change+65.3% (Feb 21, 2024)
Weeks tracked331
Tracking sinceApr 22, 2020

Price History

1W

+12.2%

1M

+12.2%

3M

+19.8%

6M

+3.0%

1Y

+2.8%

3Y

-48.5%

5Y

-73.8%

All

-63.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LANSOPRAZOLE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of LANSOPRAZOLE DR 15 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG ODT, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.8751 per EA (NDC 68382077177), effective Aug 19, 2026.

How has the price of LANSOPRAZOLE DR 15 MG ODT changed over time?

Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG ODT has declined 63.5%. It has been tracked across 331 weekly CMS publications since Apr 22, 2020.

What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG ODT?

Since Apr 22, 2020, the NADAC for LANSOPRAZOLE DR 15 MG ODT has ranged from a low of $1.5080 (Apr 22, 2026) to a high of $9.1795 (Jul 15, 2020), with a median of $3.6404 per EA.

Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG ODT?

No other NADAC-published product currently shares the active ingredient and strength of LANSOPRAZOLE DR 15 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LANSOPRAZOLE DR 15 MG ODT?

LANSOPRAZOLE DR 15 MG ODT (NDC 68382077177) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.